The Recall Desk
HighFDA (Food)·F-2946-2015·Announced 2015-08-19

Novacare Recalls Glucosamine Capsules Due to Inadequate Allergen Labeling

Novacare, LLC is recalling 961 bottles of Glucosamine 750 mg capsules nationwide because the product has inadequate allergen labeling.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall is classified as FDA Class II and involves inadequate allergen labeling, which falls under the rubric criteria for 'Allergen mislabeling on common allergens' or 'risk-of-harm products where injury has not yet been reported.'

Plain-English summary

Novacare, LLC is conducting a field action on 961 bottles of Glucosamine 750 mg 120 ct capsules. The recall is being issued due to inadequate allergen labeling on the product.

The affected product is distributed nationwide, with no foreign or VA/govt/military consignees. The specific lot numbers involved are 4102801, 2071918.2, 2061401, and 2032006. The product is a capsule dosage form intended to be taken as 1-2 capsules, 750 mg each, three times daily with meals.

Consumers should stop using the product and check their lot numbers against the list provided. The source text does not specify a particular return address or refund process, so consumers should contact the manufacturer or retailer for further instructions.

The recalled product

Product
Glucosamine 750 mg 120 ct, Capsule, Dosage: 12 capsules, 750 mg ea., three times daily with meals
Manufacturer
Novacare, LLC
Category
Food — Dietary Supplement
Hazard
Affected units
961

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (4)

  • Lot #s: 4102801
  • 2071918.2
  • 2061401
  • 2032006

Distribution

Distributed nationwide across the United States.

Related recalls

Same manufacturer · Novacare, LLC

See all →

Same hazard · allergen mislabeling

See all →